These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30177112)

  • 1. Predictive Value of Models for End-Stage Liver Disease Score in Patients With Pulsatile Flow POLVAD MEV Left Ventricular Assist Device Support.
    Nadziakiewicz P; Szyguła-Jurkiewicz B; Pacholewicz J; Zakliczyński M; Przybyłowski P; Krauchuk A; Łowicka M; Zembala M
    Transplant Proc; 2018 Sep; 50(7):2075-2079. PubMed ID: 30177112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Mechanical Circulatory Support by the Use of Pulsatile Left Ventricular Assist Devices Polvad MEV and Continuous Flow Heart Ware and Heart Mate II in a Single-Center Experience.
    Nadziakiewicz P; Pacholewicz J; Zakliczynski M; Niklewski T; Borkowski J; Hrapkowicz T; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1770-4. PubMed ID: 27496489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
    Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
    ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.
    Yost GL; Coyle L; Bhat G; Tatooles AJ
    J Artif Organs; 2016 Mar; 19(1):21-8. PubMed ID: 26187243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy.
    Bonde P; Ku NC; Genovese EA; Bermudez CA; Bhama JK; Ciarleglio MM; Cong X; Teuteberg JJ; Kormos RL
    Ann Thorac Surg; 2012 May; 93(5):1541-7; discussion 1547-8. PubMed ID: 22480391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-Stage Liver Disease Models and Outcomes in Pediatric Patients Supported With Short-Term Continuous-Flow Ventricular Assist Devices.
    Malik G; Pidborochynski T; Buchholz H; Freed DH; Al-Aklabi M; Bozso SJ; Choudhry S; Anand V; Holinski P; Conway J
    ASAIO J; 2020 Aug; 66(8):933-938. PubMed ID: 32740355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Left Ventricular Assist Device Support on End-Organ Function in Patients With Heart Failure: Comparison of Pulsatile- and Continuous-Flow Support in a Single-Center Experience.
    Nadziakiewicz P; Szygula-Jurkiewicz B; Niklewski T; Pacholewicz J; Zakliczynski M; Borkowski J; Hrapkowicz T; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1775-80. PubMed ID: 27496490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant.
    Szyguła-Jurkiewicz B; Nadziakiewicz P; Zakliczynski M; Szczurek W; Chraponski J; Zembala M; Gasior M
    Transplant Proc; 2016 Jun; 48(5):1756-60. PubMed ID: 27496486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative hepatic dysfunction could predict postoperative mortality and morbidity in patients undergoing cardiac surgery: Utilization of the MELD scoring system.
    Murata M; Kato TS; Kuwaki K; Yamamoto T; Dohi S; Amano A
    Int J Cardiol; 2016 Jan; 203():682-9. PubMed ID: 26583843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
    PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right Ventricular Function in Patients With Left Ventricular Assist Device Support by Pulsatile Polvad MEV and Continuous-Flow Pumps Heartware and Heartmate II.
    Nadziakiewicz P; Borkowski J; Szygula-Jurkiewicz B; Niklewski T; Pacholewicz J; Zakliczynski M; Hrapkowicz T; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1786-90. PubMed ID: 27496492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of ventricular assist device risk scores' capacity to predict cardiopulmonary exercise parameters.
    Dorken Gallastegi A; Öztürk P; Demir E; Engin Ç; Nalbantgil S; Yağdı T; Özbaran M
    Interact Cardiovasc Thorac Surg; 2020 Feb; 30(2):223-228. PubMed ID: 31628803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.
    Szyguła-Jurkiewicz B; Zakliczyński M; Szczurek W; Nadziakiewicz P; Gąsior M; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1703-7. PubMed ID: 27496475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.